Search hospitals > Minnesota > Minneapolis
Unity Hospital
Claim this profileMinneapolis, Minnesota 55432
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Adenocarcinoma
518 reported clinical trials
13 medical researchers
Summary
Unity Hospital is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. Unity Hospital is involved with conducting 518 clinical trials across 523 conditions. There are 13 research doctors associated with this hospital, such as David M. King, Daniel M. Anderson, Yan Ji, and Pamala A. Pawloski.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
David M. KingPark Nicollet Clinic - Saint Louis Park7 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
97 reported clinical trials
159 drugs studied
Daniel M. AndersonRegions Hospital4 years of reported clinical research
Expert in Cancer
Expert in Tumors
60 reported clinical trials
108 drugs studied
Yan JiRegions Hospital1 year of reported clinical research
Expert in Cancer
Studies Breast Cancer
30 reported clinical trials
74 drugs studied
Pamala A. PawloskiPark Nicollet Clinic - Saint Louis Park5 years of reported clinical research
Studies Cancer
Studies Tumors
14 reported clinical trials
19 drugs studied
Clinical Trials running at Unity Hospital
Breast Cancer
Esophageal Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Prostate Cancer
Cancer
Esophageal Carcinoma
Non-Small Cell Lung Cancer
Lung Cancer
Bladder Cancer
Gastric Cancer
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Unity Hospital?
Unity Hospital is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. Unity Hospital is involved with conducting 518 clinical trials across 523 conditions. There are 13 research doctors associated with this hospital, such as David M. King, Daniel M. Anderson, Yan Ji, and Pamala A. Pawloski.
Where is Unity Hospital located?
To reach Unity Hospital in Minneapolis, take I-35W South and exit at Highway 10 West towards Central Avenue (MN 65), then head south on Central Avenue. For the most accurate route, consider using real-time driving directions from Waze.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Unity Hospital, please contact the dedicated department at (585) 922-1900.
What insurance does Unity Hospital accept?
Unity Hospital accepts a broad range of insurance plans, including but not limited to Aetna, Ambetter/Arkansas Total Care, Amco, Blue Advantage, Blue Cross/Blue Shield, Cigna, Coventry, Empower, and more. The hospital also accepts Medicare, Medicaid, and various commercial insurances. It is advised to confirm coverage with your specific health plan or provider.
What awards or recognition has Unity Hospital received?
Unity Hospital, located in Minneapolis, Minnesota, is renowned for its outstanding quality care. It has been honored with several prestigious awards, including being named a Solucient® top 100 U.S. cardiovascular center and a Neuroscience Center of Excellence in 2006. Additionally, it received the 2006 Innovation of the Year in Patient Care and Best Minnesota Hospital Workplace Awards from the Minnesota Hospital Association, and operates internationally recognized research laboratories in cardiac pathology, including the Jesse E. Edwards Cardiovascular Registry.